دورية أكاديمية
أعرض في EDS

Immunoengineering strategies to enhance vascularization and tissue regeneration.

التفاصيل البيبلوغرافية
العنوان: Immunoengineering strategies to enhance vascularization and tissue regeneration.
المؤلفون: Zarubova J; Department of Bioengineering, University of California, Los Angeles, CA 90095, USA; Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Prague 14220, Czech Republic., Hasani-Sadrabadi MM; Department of Bioengineering, University of California, Los Angeles, CA 90095, USA., Ardehali R; Division of Cardiology, Department of Internal Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA; Eli and Edythe Broad Stem Cell Research Center, University of California, Los Angeles, CA 90095, USA; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA., Li S; Department of Bioengineering, University of California, Los Angeles, CA 90095, USA; Eli and Edythe Broad Stem Cell Research Center, University of California, Los Angeles, CA 90095, USA; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. Electronic address: songli@ucla.edu.
المصدر: Advanced drug delivery reviews [Adv Drug Deliv Rev] 2022 May; Vol. 184, pp. 114233. Date of Electronic Publication: 2022 Mar 15.
نوع المنشور: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Publishers, B.V Country of Publication: Netherlands NLM ID: 8710523 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8294 (Electronic) Linking ISSN: 0169409X NLM ISO Abbreviation: Adv Drug Deliv Rev Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Amsterdam : Elsevier Science Publishers, B.V., c1987-
مواضيع طبية MeSH: Macrophages* , Wound Healing*, Biocompatible Materials ; Humans ; Immunity
مستخلص: Immune cells have emerged as powerful regulators of regenerative as well as pathological processes. The vast majority of regenerative immunoengineering efforts have focused on macrophages; however, growing evidence suggests that other cells of both the innate and adaptive immune system are as important for successful revascularization and tissue repair. Moreover, spatiotemporal regulation of immune cells and their signaling have a significant impact on the regeneration speed and the extent of functional recovery. In this review, we summarize the contribution of different types of immune cells to the healing process and discuss ways to manipulate and control immune cells in favor of vascularization and tissue regeneration. In addition to cell delivery and cell-free therapies using extracellular vesicles, we discuss in situ strategies and engineering approaches to attract specific types of immune cells and modulate their phenotypes. This field is making advances to uncover the extraordinary potential of immune cells and their secretome in the regulation of vascularization and tissue remodeling. Understanding the principles of immunoregulation will help us design advanced immunoengineering platforms to harness their power for tissue regeneration.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2022 Elsevier B.V. All rights reserved.)
References: Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23551-23561. (PMID: 31685607)
J Vasc Surg. 2011 Oct;54(4):1032-41. (PMID: 21684715)
Biomaterials. 2018 Nov;182:202-215. (PMID: 30138783)
Nat Mater. 2015 Jul;14(7):737-44. (PMID: 26030305)
Oncogene. 2012 Jun 28;31(26):3111-23. (PMID: 22056877)
ACS Appl Mater Interfaces. 2014 Jun 11;6(11):8505-12. (PMID: 24844318)
Vascul Pharmacol. 2010 Sep-Oct;53(3-4):130-7. (PMID: 20546942)
J Clin Invest. 2019 Jul 1;129(7):2608-2618. (PMID: 31259743)
Nat Commun. 2016 Dec 14;7:13885. (PMID: 27966526)
Trends Biotechnol. 2020 Apr;38(4):418-431. (PMID: 31699534)
Mol Ther. 2009 Jun;17(6):1109-15. (PMID: 19352324)
Front Immunol. 2014 Sep 02;5:420. (PMID: 25228902)
Immunobiology. 2013 Apr;218(4):455-64. (PMID: 22749980)
Nat Biotechnol. 2015 Jan;33(1):97-101. (PMID: 25503382)
Immunology. 2009 Nov;128(3):369-80. (PMID: 20067537)
Wound Repair Regen. 2017 Sep;25(5):774-791. (PMID: 28922523)
Curr Opin Biotechnol. 2020 Dec;66:236-245. (PMID: 33007634)
Platelets. 2015;26(3):199-211. (PMID: 24832135)
Chem Rev. 2005 Jul;105(7):2745-64. (PMID: 16011323)
Stroke. 2013 Dec;44(12):3498-508. (PMID: 24135932)
Microcirculation. 2016 Feb;23(2):95-121. (PMID: 26614117)
Adv Funct Mater. 2020 Sep 10;30(37):. (PMID: 32952493)
Circ Res. 2011 Nov 11;109(11):1280-9. (PMID: 21959218)
Front Immunol. 2018 Oct 02;9:2171. (PMID: 30356867)
J Neurosci. 2017 Mar 15;37(11):2916-2930. (PMID: 28193684)
Circ Res. 2015 May 22;116(11):e99-132. (PMID: 25931450)
Theranostics. 2017 Jan 1;7(1):81-96. (PMID: 28042318)
Mol Ther. 2012 Nov;20(11):2168-79. (PMID: 23070116)
Thromb Haemost. 2014 Dec;112(6):1219-29. (PMID: 25209750)
Sci Transl Med. 2013 Mar 20;5(177):177ra36. (PMID: 23515078)
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1854-9. (PMID: 25012127)
Biomaterials. 2018 Sep;178:681-696. (PMID: 29705000)
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12485-90. (PMID: 11606713)
Circulation. 2010 Aug 3;122(5):495-506. (PMID: 20644015)
Int Rev Cell Mol Biol. 2011;288:101-65. (PMID: 21482411)
Immunity. 2015 Mar 17;42(3):419-30. (PMID: 25786174)
Nat Med. 2000 Jan;6(1):49-55. (PMID: 10613823)
Nat Rev Cardiol. 2018 Sep;15(9):505-522. (PMID: 30065258)
Front Physiol. 2018 May 01;9:419. (PMID: 29765329)
J Immunol. 2010 Aug 1;185(3):1442-9. (PMID: 20610648)
Trends Immunol. 2019 Jul;40(7):635-647. (PMID: 31160208)
Nat Biomed Eng. 2017;1:. (PMID: 28868207)
Circ Res. 2014 Jun 20;115(1):55-67. (PMID: 24786398)
J Pharm Sci. 2015 Feb;104(2):705-13. (PMID: 25393546)
Biomaterials. 2013 Jun;34(18):4439-51. (PMID: 23515178)
ACS Appl Mater Interfaces. 2019 Oct 16;11(41):37421-37433. (PMID: 31525863)
Nanomedicine. 2015 Apr;11(3):645-55. (PMID: 25596340)
Biophys J. 2012 Jan 18;102(2):L5-7. (PMID: 22339876)
PLoS One. 2009 Jun 22;4(6):e5994. (PMID: 19543393)
Blood. 2004 Jan 15;103(2):617-26. (PMID: 14512298)
Nat Rev Cancer. 2017 Aug;17(8):457-474. (PMID: 28706266)
Nature. 2013 Apr 11;496(7444):238-42. (PMID: 23535595)
Trends Immunol. 2010 Aug;31(8):318-24. (PMID: 20620114)
Ann Biomed Eng. 2015 Mar;43(3):628-40. (PMID: 25316589)
Adv Wound Care (New Rochelle). 2014 Apr 1;3(4):315-323. (PMID: 24757588)
Stem Cells. 2017 Apr;35(4):851-858. (PMID: 28294454)
Front Immunol. 2015 Nov 25;6:602. (PMID: 26635814)
PLoS One. 2017 Jul 28;12(7):e0182381. (PMID: 28753648)
J Control Release. 2014 Nov 28;194:138-47. (PMID: 25173841)
J Exp Med. 2007 Nov 26;204(12):3037-47. (PMID: 18025128)
J Nanobiotechnology. 2018 Aug 30;16(1):61. (PMID: 30165851)
Adv Mater. 2021 Mar;33(12):e2004172. (PMID: 33565154)
Trends Immunol. 2007 Sep;28(9):385-92. (PMID: 17692569)
Wound Repair Regen. 2010 Nov-Dec;18(6):586-93. (PMID: 20946144)
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17253-8. (PMID: 24101477)
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):14947-14954. (PMID: 31285339)
Lancet. 2016 Jun 11;387(10036):2412-21. (PMID: 27059887)
Acta Biomater. 2019 Apr 15;89:152-165. (PMID: 30862554)
Nat Rev Immunol. 2022 Aug;22(8):484-498. (PMID: 34815556)
JCI Insight. 2017 Oct 5;2(19):. (PMID: 28978794)
Front Immunol. 2019 Jul 19;10:1706. (PMID: 31379883)
Am J Pathol. 2011 Sep;179(3):1243-56. (PMID: 21762674)
Nat Mater. 2021 Apr;20(4):560-569. (PMID: 33168979)
Biomaterials. 2018 Sep;178:109-121. (PMID: 29920403)
Adv Sci (Weinh). 2019 Aug 27;6(20):1900513. (PMID: 31637157)
Integr Biol (Camb). 2017 Mar 1;9(3):211-222. (PMID: 28252135)
ACS Biomater Sci Eng. 2015 Jul 13;1(7):481-493. (PMID: 26280020)
Cell Metab. 2020 Jun 2;31(6):1136-1153.e7. (PMID: 32492393)
Nat Mater. 2016 Sep;15(9):1037-46. (PMID: 27213956)
Matrix Biol. 2014 Jul;37:49-59. (PMID: 24887393)
Biomaterials. 2020 Sep;252:120058. (PMID: 32413594)
Am J Pathol. 2013 Feb;182(2):505-15. (PMID: 23201131)
Wound Repair Regen. 2014 Sep-Oct;22(5):613-21. (PMID: 25041740)
Blood. 2012 Nov 29;120(23):4653-62. (PMID: 22966168)
Antioxid Redox Signal. 2019 Apr 20;30(12):1553-1598. (PMID: 30070144)
Nature. 2017 Jun 22;546(7659):498-503. (PMID: 28607485)
Front Immunol. 2018 Nov 15;9:2650. (PMID: 30524429)
Circulation. 2003 Mar 18;107(10):1359-65. (PMID: 12642354)
J Am Coll Cardiol. 2008 Oct 14;52(16):1302-11. (PMID: 18929241)
Diabetes. 2010 Nov;59(11):2872-82. (PMID: 20693346)
Acta Biomater. 2018 Apr 15;71:132-147. (PMID: 29462712)
Biomaterials. 2014 May;35(15):4477-88. (PMID: 24589361)
Nano Lett. 2017 Nov 8;17(11):7045-7054. (PMID: 28994285)
Nat Aging. 2021 Jul;1:598-615. (PMID: 34888528)
Sci Transl Med. 2015 Jun 10;7(291):291ra94. (PMID: 26062846)
Am J Physiol Heart Circ Physiol. 2019 Sep 1;317(3):H581-H596. (PMID: 31322426)
Nat Immunol. 2013 Sep;14(9):949-58. (PMID: 23933892)
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):7968-73. (PMID: 24843171)
J Mater Chem B. 2018 May 28;6(20):3274-3284. (PMID: 32254385)
Nanoscale. 2019 Oct 3;11(38):17699-17708. (PMID: 31545331)
Cancer Cell. 2010 Feb 17;17(2):121-34. (PMID: 20138013)
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14430-5. (PMID: 25246564)
Biomaterials. 2009 Mar;30(8):1482-91. (PMID: 19121538)
Nature. 2011 May 19;473(7347):298-307. (PMID: 21593862)
Regen Biomater. 2017 Feb;4(1):55-68. (PMID: 28149530)
Nano Lett. 2016 Apr 13;16(4):2198-204. (PMID: 26990380)
Am J Pathol. 2010 Jan;176(1):496-503. (PMID: 19948826)
Biomaterials. 2014 Jun;35(18):4919-28. (PMID: 24661551)
Nature. 2015 Nov 19;527(7578):329-35. (PMID: 26524530)
J Biomed Mater Res A. 2016 Apr;104(4):942-56. (PMID: 26704185)
J Tissue Eng Regen Med. 2021 Jan;15(1):24-36. (PMID: 33217150)
Nat Biotechnol. 2018 Sep;36(8):707-716. (PMID: 29985479)
Sci Adv. 2020 Aug 21;6(34):. (PMID: 32937368)
Br J Haematol. 2004 Feb;124(3):376-84. (PMID: 14717787)
Gerontology. 2013;59(2):159-64. (PMID: 23108154)
Cell Rep. 2018 Aug 7;24(6):1610-1626. (PMID: 30089270)
EMBO J. 2018 Jul 2;37(13):. (PMID: 29866703)
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10648-10653. (PMID: 30275293)
Nat Biomed Eng. 2018 May;2(5):293-303. (PMID: 30271672)
Circulation. 2003 Jul 15;108(2):205-10. (PMID: 12821542)
Int J Mol Sci. 2014 Dec 03;15(12):22342-64. (PMID: 25479079)
Cardiovasc Res. 2004 Aug 1;63(2):226-35. (PMID: 15249180)
Theranostics. 2018 Jan 1;8(1):237-255. (PMID: 29290805)
Acta Biomater. 2014 Nov;10(11):4723-4729. (PMID: 25038462)
Sci Adv. 2020 Dec 4;6(49):. (PMID: 33277245)
Nat Rev Immunol. 2011 Oct 14;11(11):723-37. (PMID: 21997792)
Front Immunol. 2017 Jul 21;8:837. (PMID: 28785263)
Blood. 2009 Aug 13;114(7):1387-95. (PMID: 19491394)
Int J Mol Sci. 2017 Jul 03;18(7):. (PMID: 28671607)
Biomed Mater. 2018 Sep 21;13(6):065010. (PMID: 30129563)
Acta Biomater. 2020 Jun;109:267-279. (PMID: 32251781)
J Clin Invest. 2014 Mar;124(3):1382-92. (PMID: 24569380)
J Exp Med. 1962 Mar 1;115:453-66. (PMID: 13872176)
J Cell Mol Med. 2009 Sep;13(9B):3485-96. (PMID: 19228260)
J Biomed Mater Res A. 2018 Dec;106(12):3001-3008. (PMID: 30303608)
Blood. 2010 Nov 25;116(22):4720-30. (PMID: 20739660)
Biomaterials. 2009 Dec;30(36):6986-95. (PMID: 19783044)
ACS Nano. 2013 Sep 24;7(9):7698-710. (PMID: 24004438)
Exp Cell Res. 2020 Sep 15;394(2):112146. (PMID: 32561287)
Curr Opin Immunol. 2018 Aug;53:180-186. (PMID: 29879585)
PLoS One. 2014 Mar 11;9(3):e91574. (PMID: 24618995)
Front Immunol. 2019 Jun 11;10:1320. (PMID: 31244858)
J Exp Med. 2000 Oct 2;192(7):1069-74. (PMID: 11015447)
Adv Healthc Mater. 2018 Oct;7(19):e1800675. (PMID: 30106513)
Biomaterials. 2018 Sep;178:95-108. (PMID: 29920405)
ACS Biomater Sci Eng. 2019 Oct 14;5(10):5548-5557. (PMID: 33464074)
Nature. 2015 Oct 1;526(7571):118-21. (PMID: 26374997)
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4930-4. (PMID: 16549762)
Matter. 2021 May 5;4(5):1528-1554. (PMID: 33723531)
Circulation. 2004 Apr 6;109(13):1660-7. (PMID: 15023888)
Tissue Eng Part B Rev. 2014 Feb;20(1):28-39. (PMID: 23678952)
Nat Rev Mol Cell Biol. 2012 Mar 07;13(4):225-238. (PMID: 22395773)
FEBS Lett. 2017 Oct;591(19):3007-3021. (PMID: 28555751)
Sci Adv. 2016 Jun 10;2(6):e1600502. (PMID: 27386584)
Biomaterials. 2010 May;31(13):3536-42. (PMID: 20122725)
Blood. 2009 Jul 9;114(2):237-47. (PMID: 19339693)
Front Pharmacol. 2019 Jan 25;10:22. (PMID: 30740053)
Nat Commun. 2019 Aug 2;10(1):3491. (PMID: 31375674)
Blood Cells Mol Dis. 2005 Sep-Oct;35(2):158-68. (PMID: 16087368)
J Immunol. 2011 Mar 15;186(6):3299-303. (PMID: 21317389)
Front Immunol. 2014 Oct 27;5:533. (PMID: 25386179)
Cancer Cell. 2009 Sep 8;16(3):183-94. (PMID: 19732719)
Science. 2016 Apr 15;352(6283):366-70. (PMID: 27081073)
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):855-60. (PMID: 16418262)
Elife. 2017 Jun 08;6:. (PMID: 28594327)
ACS Nano. 2014 Jan 28;8(1):483-494. (PMID: 24383518)
Circ Res. 1997 Jun;80(6):829-37. (PMID: 9168785)
Nat Commun. 2021 May 31;12(1):3256. (PMID: 34059671)
Integr Biol (Camb). 2015 Oct;7(10):1272-84. (PMID: 26156536)
Cell. 2009 Jun 12;137(6):1124-35. (PMID: 19524514)
PLoS One. 2013 May 29;8(5):e64159. (PMID: 23734190)
FASEB J. 2019 Jan;33(1):34-48. (PMID: 30085886)
Sci Adv. 2019 Jul 31;5(7):eaav6313. (PMID: 31392268)
Angiogenesis. 2018 Aug;21(3):425-532. (PMID: 29766399)
Biotechnol Bioeng. 2018 Apr;115(4):1086-1095. (PMID: 29280498)
Front Immunol. 2021 Mar 26;12:636585. (PMID: 33841419)
Sci Adv. 2020 May 01;6(18):eaay6391. (PMID: 32494664)
Nat Biomed Eng. 2018 Dec;2(12):942-954. (PMID: 30581652)
PLoS One. 2015 Jul 01;10(7):e0131643. (PMID: 26132702)
Biotechniques. 2011 Oct;51(4):239-40, 242, 244 passim. (PMID: 21988690)
Biomaterials. 2015 Jan;37:194-207. (PMID: 25453950)
J Control Release. 2015 May 10;205:35-44. (PMID: 25483424)
J Immunol. 2015 Dec 15;195(12):5667-77. (PMID: 26538392)
Cell. 2017 Jun 1;169(6):1119-1129.e11. (PMID: 28552347)
ACS Omega. 2018 Dec 27;3(12):18444-18455. (PMID: 31458417)
Nat Biotechnol. 2005 Jul;23(7):879-84. (PMID: 15965465)
Cell Rep. 2016 Oct 11;17(3):684-696. (PMID: 27732846)
Am J Pathol. 2009 Aug;175(2):649-60. (PMID: 19574428)
Lab Chip. 2020 Mar 17;20(6):1153-1166. (PMID: 32100769)
Front Physiol. 2013 May 28;4:122. (PMID: 23755018)
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19446-51. (PMID: 18042719)
Cardiovasc Res. 2011 May 1;90(2):364-72. (PMID: 21156823)
Curr Trends Immunol. 2015;16:65-78. (PMID: 27818580)
Cancer Lett. 2017 Jan 28;385:261-270. (PMID: 27826039)
Acta Biomater. 2012 Jul;8(7):2648-58. (PMID: 22522128)
Trends Immunol. 2004 Apr;25(4):201-9. (PMID: 15039047)
Cardiovasc Res. 2016 May 1;110(1):51-61. (PMID: 26825554)
Sci Transl Med. 2015 Nov 25;7(315):315ra190. (PMID: 26606969)
Immunol Res. 2014 May;58(2-3):186-92. (PMID: 24614953)
Nature. 2014 Jul 10;511(7508):167-76. (PMID: 25008522)
Biotechnol Bioeng. 2014 Jun;111(6):1210-21. (PMID: 24375008)
Acta Biomater. 2021 May;126:31-44. (PMID: 33722787)
Sci Transl Med. 2018 Jun 6;10(444):. (PMID: 29875202)
Sci Transl Med. 2021 Mar 10;13(584):. (PMID: 33692129)
Circulation. 2005 Aug 30;112(9 Suppl):I150-6. (PMID: 16159808)
Acta Biomater. 2012 Mar;8(3):978-87. (PMID: 22166681)
Front Bioeng Biotechnol. 2020 May 19;8:369. (PMID: 32509739)
Stem Cell Res Ther. 2013 Nov 01;4(6):134. (PMID: 24405629)
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):5908-5913. (PMID: 30850545)
Wound Repair Regen. 2021 Nov;29(6):938-950. (PMID: 34687253)
Nat Commun. 2017 Aug 29;8(1):371. (PMID: 28851858)
ACS Biomater Sci Eng. 2020 May 11;6(5):3091-3102. (PMID: 33463297)
Annu Rev Biomed Eng. 2012;14:1-16. (PMID: 22524388)
Immunol Cell Biol. 2010 Feb;88(2):165-71. (PMID: 19841638)
Tissue Eng Part B Rev. 2008 Jun;14(2):149-65. (PMID: 18498217)
Cell Transplant. 2008;17(1-2):211-22. (PMID: 18468252)
Nat Mater. 2018 Dec;17(12):1134-1144. (PMID: 30349032)
J Immunol. 2017 Feb 15;198(4):1387-1394. (PMID: 28167649)
ACS Appl Mater Interfaces. 2015 Dec 30;7(51):28665-72. (PMID: 26605491)
Adv Mater. 2014 Oct;26(38):6530-41. (PMID: 25155610)
Sci Immunol. 2019 Oct 11;4(40):. (PMID: 31604843)
PLoS One. 2015 Jun 03;10(6):e0128094. (PMID: 26039259)
J Cell Biochem. 2019 Jul;120(7):10945-10951. (PMID: 30793361)
Mol Ther. 2012 Jun;20(6):1280-6. (PMID: 22453769)
Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):520-6. (PMID: 16397137)
معلومات مُعتمدة: R01 CA234343 United States CA NCI NIH HHS; R01 HL148714 United States HL NHLBI NIH HHS; R01 DK112939 United States DK NIDDK NIH HHS; R01 HL149940 United States HL NHLBI NIH HHS; R56 DE029157 United States DE NIDCR NIH HHS
فهرسة مساهمة: Keywords: Biomaterial; Cell delivery; Extracellular vesicles; Immune cell metabolism; Immunomodulation; Macrophages; Neutrophils; Patterning; Stiffness; T cells
المشرفين على المادة: 0 (Biocompatible Materials)
تواريخ الأحداث: Date Created: 20220319 Date Completed: 20220426 Latest Revision: 20231219
رمز التحديث: 20231219
مُعرف محوري في PubMed: PMC10726003
DOI: 10.1016/j.addr.2022.114233
PMID: 35304171
قاعدة البيانات: MEDLINE
الوصف
تدمد:1872-8294
DOI:10.1016/j.addr.2022.114233